# Study Evaluating ISM5411 Administered Orally to Healthy Volunteers

> **NCT06012578** · PHASE1 · COMPLETED · sponsor: **InSilico Medicine Hong Kong Limited** · enrollment: 79 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** ISM5411
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06012578
- **Lead sponsor:** InSilico Medicine Hong Kong Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-08
- **Primary completion:** 2024-09-04
- **Final completion:** 2024-09-04
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2024-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06012578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06012578, "Study Evaluating ISM5411 Administered Orally to Healthy Volunteers". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06012578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*